Generation Bio EBIT Margin 2020-2023 | GBIO
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Generation Bio (GBIO) over the last 10 years. The current EBIT profit margin for Generation Bio as of December 31, 2023 is .
| Generation Bio EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.188B | $0.006B |
| Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.751B | 5.69 |
| Dr Reddy's Laboratories (RDY) | India | $12.261B | 19.39 |
| Aspen Pharmacare (APNHY) | South Africa | $5.328B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $4.794B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.201B | 2.50 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.016B | 13.80 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.655B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.454B | 0.00 |
| Personalis (PSNL) | United States | $0.074B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.068B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.026B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.020B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |